Hepatobiliary Complications in Critically Ill Patients

Area of Science:

• Hepatology
• Critical Care Medicine
• Systemic Inflammatory Response Syndrome

Background:

• Critically ill patients often develop systemic inflammatory response syndrome (SIRS), reflecting liver injury.
• Hepatic congestion is a primary risk factor for hypoxic liver injury, a common cause of hepatocellular damage.
• Cholestatic liver injury is prevalent in critical illness due to impaired bile acid handling.

Purpose of the Study:

• To elucidate the mechanisms of liver injury in critically ill patients.
• To investigate the role of farnesoid X receptor (FXR) in cholestatic liver injury.
• To understand alterations in bile acid metabolism and xenobiotic processing in critical illness.

Main Methods:

• Review of existing literature on liver injury in critical care.
• Analysis of pathways involved in systemic inflammation and hepatic response.
• Examination of bile acid metabolism and FXR signaling in liver injury.

Main Results:

• Systemic inflammation significantly impacts liver function and injury patterns.
• Hepatic congestion exacerbates hypoxic liver injury.
• Inhibition of FXR leads to cholestatic liver injury and altered bile acid profiles.
• Cytotoxic bile acids increase, and xenobiotic processing is disturbed.

Conclusions:

• Liver injury in critically ill patients is multifactorial, involving inflammation, congestion, and cholestasis.
• FXR inhibition is a key mechanism driving cholestatic liver injury in critical illness.
• Altered bile acid pools and impaired detoxification contribute to overall liver damage.